Evidence map›Paper›PMID 15640619›Full record

ReviewCancer biology & therapy2004

Death receptor signals to mitochondria.

Roya Khosravi-Far, Mauro Degli Esposti

Open access · bronzeAbstract readReview
In one paragraph

Review in Cancer biology & therapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 206 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Role of cytosolic and endoplasmic reticulum CaPflugers Archiv : European journal of physiology · 2024
    Review
  11. Article
  12. Potential Otubain1 Inhibitor, an Approach for a Treatment against Breast Cancer.International journal of molecular and cellular medicine · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Roya Khosravi-FarDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, 99 Brookline Ave., Boston, Massachusetts 02215, USA. rkhosrav@bidmc.harvard.edu
Mauro Degli Esposti
Beth Israel Deaconess Medical Center · US

Funding

Tumor Selective Apoptosis by TRAILR01HL080192 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KHOSRAVI-FAR, ROYA · 2005 to 2010
$3.6M
NHLBI NIH HHS 1 HL080192NHLBI NIH HHS R01 HL080192
6 · The paper itself

Abstract

Apoptosis is the best-characterized form of programmed cell death (PCD) and is of fundamental importance in tissue homeostasis. In mammalian systems, there are two major pathways that are involved in the initiation of apoptosis: the "extrinsic" death receptor pathway and the "intrinsic" mitochondrial pathway. Although these pathways act independently to initiate the death machinery in some cellular systems, in many cell types, including numerous tumor cells, there is delicate coordination and cross talk between the extrinsic and intrinsic pathways, which leads to the activation of the executioner caspase cascade. Additionally, there appears to be a fine balance between the caspase-mediated arm of death receptor signaling that engages mitochondria and the caspase-independent arm that promotes vacuole proliferation in many cells. Here, we review our current knowledge about the layers of complexity that are posed by the interactions between death receptor-induced pathways and how they influence mitochondria to regulate cellular life and death decisions.

Indexed as

Signal TransductionAnimalsApoptosisfas ReceptorHumansMitochondriaReceptor Cross-TalkReceptors, Tumor Necrosis Factorfas ReceptorReceptors, Tumor Necrosis Factor

Identifiers

PMID15640619
PMCPMC2941887
OpenAlexW2017726148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.